NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

There are so many flaws in the going after it alone story I can not even begin to tell you. The story foretold by Les that because they know 90 GBM surgeons/MDs in the US they can now somehow easily sell DCVAXL for GBM in the EU/US/Canada and the UK is right out laughable.

Just to give you an idea
There are 3,700 neurosurgeons who work in more than 5,700 hospitals in the U.S.
there are 13,146 oncologists engaged in active patient care in 1638 oncology practices in the US
There are 14,000 cases of GBM in the US
there are 16,837 oncologists engaged in active patient care in 2090 oncology practices in the EU
There are 13,200 neurosurgeons in the EU
There are 22,000 people per year in the EU diagnosed with GBM
Im not even going to mention Canada, Switzerland, and the UK.

But sure their network of 90 GBM surgeons/MDs in the US will suffice to cater to the US/EU/UK and Canada markets. Absurd. And no DCVAXL will not "sell" itself. No product does. And even if it would "sell itself" who will pick up to phone when Dr Schwarz from Frankfurt calls to get information for its 2 patients? Les? hahahaha come on

Look if they wanted to "go after it alone" they will need a marketing/sales/compliance/management/administration/patient care of at least 300 to 400 in specialized staff. It will cost them many years to have any kind of meaningful network and impact on thousands of hospitals and MDs. Not to mention that this specialized team will also have to negotiate with hundreds of insurance companies and dozens of EU countries to get DCVAXL reimbursement.
They have not even begun to plan to start thinking about this.

And even if NWBO would want to build a team of specialized staff then it would not only take them many years (three double that for this senior unexperienced dumb as a horse ars management) but hundreds of millions in USD per year. Such investment will never be earned back with one cancer treatment only. That is the reason why big pharma with existing networks and existing marketing/sales/compliance/management/administration/patient care teams and departments are able to launch new cancer treatments profitably. Their teams with hundreds of experienced staff are not just selling ONE cancer treatment but many, something Les already said they are not planning todo.

To sum it up.
One team of hundreds of marketing/sales/compliance/management/administration/patient carewill NOT be profitable to sell ONE cancer treatment. Let alone that NWBO is in no way shape or form capable todo so.

NWBO will be BOUGHT after FDA approval and hopefully before that.